Pharmaceutical
ChemLinkedChemicalFoodCosmeticPharmaceuticalJapanAgrochemicalSustainability
News
Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
INDUSTRY
Generic Drug Biosimilar New Drug China
Monthly Report: New Drug Approvals in China | January 2025 In January 2025, China NMPA approved 32 new drugs, among which 20 are chemical drugs and 12 are biological products.
Feb 18, 2025
INDUSTRY
Generic Drug New Drug China
Monthly Report: New Drug Approvals in China | December 2024 In December 2024, China NMPA approved 45 new drugs, among which 30 are chemical drugs and 15 are biological products.
Jan 16, 2025
INDUSTRY
Innovative Drug Generic Drug New Drug China
Monthly Report: New Drug Approvals in China | November 2024 In November 2024, China NMPA approved 19 new drugs, among which 12 are chemical drugs and 7 are biological products.
Dec 10, 2024
INDUSTRY
Innovative Drug Generic Drug New Drug China
Monthly Report: New Drug Approvals in China | October 2024 In October 2024, China NMPA approved 11 new drugs, among which 6 are chemical drugs and 5 are biological products.
Nov 11, 2024
INDUSTRY
Innovative Drug OTC Drug Cancer Respiratory Disease China
An Overview of Drug Sales in China In 2023, China’s pharmaceutical market saw steady growth marked by both rising drug sales and an influx of new drug applications.
Nov 06, 2024
INDUSTRY
Pharmacopoeia Cardiovascular Disease E-commerce China
China's Pharmaceutical Retail Market Value Hits RMB 245.8 Billion in 2024H1 From January to June 2024, the pharmacy retailing market value has reached RMB 245.8 billion (about USD 34.76 billion), up by 0.4% year on year.
Oct 17, 2024
INDUSTRY
Innovative Drug Generic Drug Biosimilar New Drug China
Monthly Report: New Drug Approvals in China | September 2024 In September 2024, China NMPA approved 21 new drugs, among which 14 are chemical drugs and 7 are biological products.
Oct 14, 2024
INDUSTRY
Innovative Drug Rare Disease China
Current Landscape of Oligonucleotide Drugs in China Compared to the global market, China currently lags in the development of oligonucleotide drugs.
Oct 09, 2024
INDUSTRY
Innovative Drug Biological Product Biosimilar New Drug China
Monthly Report: New Drug Approvals in China | August 2024 In August 2024, China NMPA approved 17 new drugs, among which 7 are chemical drugs and 10 are biological products.
Sep 15, 2024
INDUSTRY
Priority Review Innovative Drug Generic Drug Biosimilar New Drug China
Monthly Report: New Drug Approvals in China | July 2024 In July 2024, China NMPA approved 20 new drugs, among which 15 are chemical drugs and 5 are biological products.
Aug 13, 2024
12345 ...9 Next
Most Popular